Douglass Brian Robb bought RGEN
October 6, 2026 · Form 4 insider transaction
Douglass Brian Robb bought 675 shares of Repligen Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
675
Price
$0.00
Total value
N/A
InsiderDouglass Brian Robb
RoleOfficer
CompanyRepligen Corporation (RGEN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 6, 2026
Filing dateOctober 8, 2026
Shares owned after675
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
225 shares will vest on each of October 6, 2027, October 6, 2028, and October 6, 2029.